Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Impact of formulation and particle size on stability and immunogenicity of oil-in-water emulsion adjuvants.

Iyer V, Cayatte C, Guzman B, Schneider-Ohrum K, Matuszak R, Snell A, Rajani GM, McCarthy MP, Muralidhara B.

Hum Vaccin Immunother. 2015;11(7):1853-64. doi: 10.1080/21645515.2015.1046660.

2.

The Split Virus Influenza Vaccine rapidly activates immune cells through Fcγ receptors.

O'Gorman WE, Huang H, Wei YL, Davis KL, Leipold MD, Bendall SC, Kidd BA, Dekker CL, Maecker HT, Chien YH, Davis MM.

Vaccine. 2014 Oct 14;32(45):5989-97. doi: 10.1016/j.vaccine.2014.07.115. Epub 2014 Sep 6.

3.

Maternal immunization with chimpanzee adenovirus expressing RSV fusion protein protects against neonatal RSV pulmonary infection.

Sharma A, Wendland R, Sung B, Wu W, Grunwald T, Worgall S.

Vaccine. 2014 Sep 29;32(43):5761-8. doi: 10.1016/j.vaccine.2014.08.049. Epub 2014 Aug 26.

4.

Maternal vaccination: moving the science forward.

Faucette AN, Unger BL, Gonik B, Chen K.

Hum Reprod Update. 2015 Jan-Feb;21(1):119-35. doi: 10.1093/humupd/dmu041. Epub 2014 Jul 11. Review.

5.

A broadly neutralizing human monoclonal antibody exhibits in vivo efficacy against both human metapneumovirus and respiratory syncytial virus.

Schuster JE, Cox RG, Hastings AK, Boyd KL, Wadia J, Chen Z, Burton DR, Williamson RA, Williams JV.

J Infect Dis. 2015 Jan 15;211(2):216-25. doi: 10.1093/infdis/jiu307. Epub 2014 May 26.

6.

Influence of respiratory syncytial virus strain differences on pathogenesis and immunity.

Melero JA, Moore ML.

Curr Top Microbiol Immunol. 2013;372:59-82. doi: 10.1007/978-3-642-38919-1_3.

7.

Neonatal immunization with respiratory syncytial virus glycoprotein fragment induces protective immunity in the presence of maternal antibodies in mice.

Noh Y, Shim BS, Cheon IS, Rho S, Kim HJ, Choi Y, Kang CY, Chang J, Song MK, Kim JO.

Viral Immunol. 2013 Aug;26(4):268-76. doi: 10.1089/vim.2012.0087. Epub 2013 Jul 19.

8.

Need for a safe vaccine against respiratory syncytial virus infection.

Kim JY, Chang J.

Korean J Pediatr. 2012 Sep;55(9):309-15. doi: 10.3345/kjp.2012.55.9.309. Epub 2012 Sep 14.

9.

The respiratory syncytial virus G protein conserved domain induces a persistent and protective antibody response in rodents.

Nguyen TN, Power UF, Robert A, Haeuw JF, Helffer K, Perez A, Asin MA, Corvaia N, Libon C.

PLoS One. 2012;7(3):e34331. doi: 10.1371/journal.pone.0034331. Epub 2012 Mar 29.

10.

Seroprevalence of pandemic (H1N1) 2009 influenza and effectiveness of 2010/2011 influenza vaccine during 2010/2011 season in Beijing, China.

Yang P, Zhang L, Shi W, Lu G, Cui S, Peng X, Zhang D, Liu Y, Liang H, Pang X, Wang Q.

Influenza Other Respir Viruses. 2012 Nov;6(6):381-8. doi: 10.1111/j.1750-2659.2011.00326.x. Epub 2011 Dec 30.

11.

Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years.

Collins PL, Melero JA.

Virus Res. 2011 Dec;162(1-2):80-99. doi: 10.1016/j.virusres.2011.09.020. Epub 2011 Sep 22. Review.

12.

Progress in respiratory virus vaccine development.

Schmidt AC.

Semin Respir Crit Care Med. 2011 Aug;32(4):527-40. doi: 10.1055/s-0031-1283289. Epub 2011 Aug 19. Review.

13.

Maternally transferred anti-factor VIII IgG reduce the anti-factor VIII humoral immune response in factor VIII-deficient mice.

Meslier Y, André S, Teyssandier M, Kaveri SV, Lacroix-Desmazes S.

Immunology. 2010 Dec;131(4):549-55. doi: 10.1111/j.1365-2567.2010.03327.x.

14.
15.

An alphavirus replicon-based human metapneumovirus vaccine is immunogenic and protective in mice and cotton rats.

Mok H, Tollefson SJ, Podsiad AB, Shepherd BE, Polosukhin VV, Johnston RE, Williams JV, Crowe JE Jr.

J Virol. 2008 Nov;82(22):11410-8. doi: 10.1128/JVI.01688-08. Epub 2008 Sep 10.

16.

Viral and host factors in human respiratory syncytial virus pathogenesis.

Collins PL, Graham BS.

J Virol. 2008 Mar;82(5):2040-55. Epub 2007 Oct 10. Review. No abstract available.

17.

The role of maternal antibodies in the emergence of severe disease as a result of fragmentation.

Fouchet D, Marchandeau S, Bahi-Jaber N, Pontier D.

J R Soc Interface. 2007 Jun 22;4(14):479-89.

18.

Nonsegmented negative-strand viruses as vaccine vectors.

Bukreyev A, Skiadopoulos MH, Murphy BR, Collins PL.

J Virol. 2006 Nov;80(21):10293-306. Review. No abstract available.

19.

An unexpected antibody response to an engineered influenza virus modifies CD8+ T cell responses.

Thomas PG, Brown SA, Yue W, So J, Webby RJ, Doherty PC.

Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2764-9. Epub 2006 Feb 10.

20.

Supplemental Content

Support Center